Abstract
Objectives
The aim of this study was to evaluate glycemic levels in diabetic patients before, during, and after extractions using 2% lidocaine with 1:100,000 epinephrine (Lido/Epi) and 3% prilocaine with 0.03 IU/mL felypressin (Prilo/Fely).
Materials and methods
A double-blind, randomized clinical trial was conducted to evaluate changes in body parameters and glycemic levels in diabetic patients undergoing two anesthetic protocols during dental extractions. During surgery, we evaluated blood pressure (BP), heart rate (HR), saturation (SpO2), and capillary glycemic levels (Gly). These parameters were measured at the following surgical moments: basal, 30 min after medication, incision, tooth removal, suture, and 30 and 60 min after anesthesia.
Results
Data analysis showed no differences between the groups considering age, weight, and time spent in surgery. Increased systolic BP and decreased diastolic BP were observed in the lido/epi group. No difference was observed in the prilo/fely group among the surgical moments or between the groups regarding BP. No difference was observed in HR and SpO2 between the groups at any surgical moment. However, differences were found when compared the differences in glycemic and basal levels in both groups with greater decreases in blood glucose values for the lido/epi group. In anxiety level evaluation, there was no difference between the different surgical moments.
Conclusion
Thus, both lido/epi and prilo/fely (maximum 3.6 mL) can be safely used in controlled diabetic patients
Clinical relevance
The use of lidocaine associated with epinephrine did not increase glycemic levels but leads to decrease over time when associated with an anxiety reduction protocol, offering some advantage over prilocaine plus felypressin for diabetic patients.
Similar content being viewed by others
References
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(1):s62–s69
Ashcroft FM, Rorsman P (2012) Diabetes mellitus and the β cell: the last ten years. Cell 148(6):1160–1171
Scheen AJ (2003) Pathophysiology of type 2 diabetes. Acta Clin Belg 58(6):335–341
Darnell JA, Saunders MJ (1990) Oral manifestations of the diabetic patient. Tex Dent J 107(2):23–27
Mayard-Pons ML, Rilliard F, Libersa JC, Musset AM, Farge P (2015) Database analysis of a French type 2 diabetic population shows a specific age pattern of tooth extractions and correlates health care utilization. J Diabetes Complications 29(8):993–997
Armfield JM, Milgrom P (2011) A clinician guide to patients afraid of dental injections and numbness. SAAD Dig 27:33–39
Galili D, Findler M, Garfunkel AA (1994) Oral and dental complications associated with diabetes and their treatment. Compendium 15(4):496–508
Rhodus NL, Vibeto BM, Hamamoto DT (2005) Glycemic control in patients with diabetes mellitus upon admission to a dental clinic: considerations for dental management. Quintessence Int 36(6):474–482
Santos-Paul MA, Neves ILI, Neves RS, Ramires JA (2015) Local anesthesia with epinephrine is safe and effective for oral surgery in patients with type 2 diabetes mellitus and coronary disease: a prospective randomized study. Clinics 70(3):185–189
Sisk AL (1992) Vasoconstrictors in local anesthesia for dentistry. Anesth Prog 39(6):187–193
Malamed SF (2019) Handbook of Local anesthesia, 7th edn. Elsevier Inc., St. Louis, Missouri
Haji UI, Siddiq M, Rao S et al (2012) Study on blood glucose concentration in patients with diabetes undergoing dental extraction under local anesthesia with and without adrenaline. J Basic Clin Physiol Pharmacol 23(4):169–171
Kalra P, Rana AS, Peravali RK, Gupta D, Jain G (2011) Comparative evaluation of local anaesthesia with adrenaline and without adrenaline on blood glucose concentration in patients undergoing tooth extractions. J Maxillofac Oral Surg 10(3):230–235
NakamuraY MK, Miura K et al (2011) Cardiovascular and sympathetic responses to dental surgery with local anesthesia. Hypertens Res 4(3):209–214
Pinheiro AC, Marques JF, Vieira MS et al (2015) Dentists’ knowledge regarding signs and symptoms of the systemic toxicity of local anesthetic solutions. RGO, Rev Gaúch Odontol 63(1):41–46
Gerlach RF, Santos JET, Escobar CAB (1998) The use of epinephrine-containing anesthetic solutions in cardiac patients: a survey. Rev Odontol Univ São Paulo 12(4):349–353
Dellovo AG, Souza LMA, de Oliveira JS, Amorim KS, Groppo FC (2019) Effects of auriculotherapy and midazolam for anxiety control in patients submitted to third molar extraction. Int J Oral Maxillofac Surg 48(5):669–674
Silveira-Souto ML, São-Mateus CR, de Almeida-Souza LM et al (2014) Effect of Erythrinamu lungu on anxiety during extraction of third molars. Med Oral Patol Oral Cir Bucal 19(5):e518–e524
Dantas LP, de Oliveira-Ribeiro A, de Almeida-Souza LM et al (2017) Effects of Passiflora incarnata and midazolam for control of anxiety in patients undergoing dental extraction. Med Oral Patol Oral Cir Bucal 22(1):e95–e101
Hersh V, Giannakopoulos H (2010) Beta-adrenergic blocking agents and dental vasoconstrictors. Dent Clin N Am 54(4):687–696
Bronzo ALA, Cardoso Junior CG, Ortega KC et al (2012) Felypressin increases blood pressure in hypertensive patients during dental procedure. Arq Bras Cardiol 99(2):724–731
Wannmacher L, Ferreira MBC (2007) Pharmacology for Dentists. 3rd. Guanabara Koogan.
Brand HS, Abrahan-Inpijn L (1996) Cardiovascular responses induced by dental treatment. Eur J Oral Sci 104:245–252
Meechan G (1991) The effects of dental local anaesthetics on blood glucose concentration in healthy volunteers and in patients having third molar surgery. Br Dent J 170(10):373–376
Herman WW, Konzelman JL, Prisant LM (2004) New national guidelines on hypertension. J Am Dent Assoc 135:576–584
Nakamura Y, Matsumura K, Miura K et al (2001) Cardiovascular and sympathetic responses to dental surgery with local anesthesia. Hypertens Res 4(3):209–214
Tily FE, Thomas S (2007) Glycemic effect of administration of epinephrine-containing local anaesthesia in patients undergoing dental extraction, a comparison between healthy and diabetic patients. Int Dent J 57(2):77–83
Khawaja NA, Khalil H, Parveen K, Alghamdi AM, Alzahrani R’A, Alherbi S’M (2014) An influence of adrenaline (1:80,000) containing local anesthesia (2% Xylocaine) on glycemic level of patients undergoing tooth extraction in Riyadh. Saudi Pharm J 22(6):545–549
Goel M, Nagpal R, Sidhu J et al (2016) Clinical assessment of impact of adrenaline on blood glucose levels in patients undergoing dental extraction. J Int Oral Health 8(4):1–4
Hargreaves KM, Dionne RA, Mueller GP, Goldstein DS, Dubner R (1986) Naloxone, fentanyl, and diazepam modify plasma beta-endorphin levels during surgery. Clin Pharmacol Ther 40:165–171
Pérusse R, Goulet JP, Turcotte JY (1992) Contraindications to vasoconstrictors in dentistry: Part I. Oral Surg Oral Med Oral Pathol 74:679–686
Balakrishnan R, Ebenezer V (2013) Contraindications of vasoconstrictor in dentistry. Biomed Pharmacol J 6(2):409–414
Clutter WE, Bier DM, Shah SD, Cryer PE (1980) Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66:94–101
Takahashi Y, Nakano M, Sano K, Kanri T (2005) The effects of epinephrine in local anesthetics on plasma catecholamine and hemodynamic responses. Odontology 93:72–79
Melo RP, Ramacciato JC, Peruzzo DC (2016) Evaluation of blood glucose in type II diabetic patients submitted to local anesthesia with different vasoconstrictors. RGO, Rev Gaúch Odontol 64(4):425–431
Pradeep PS, Ganesh PB, Padmanabh M et al (2015) Comparison of glycemic effect of adrenalin containing local anesthetic in diabetic and non-diabetic patient undergoing minor oral surgical procedure. J of Evidence Based Med & Hlthcare 2(53):8737–8740
Cowan A (1969) Clinical assessment of a new vasoconstrictor agent, octapressin. Int Dent J 19:297–307
Newcomb GM, Waite IM (1972) The effectiveness of two local analgesic preparations in reducing haemorrhage during periodontal surgery. J Dent 1:37–42
Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M (2001) Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharmacol Ther 26(5):363–367
Acknowledgments
The Federal University of Sergipe, through the Pro-Rector of Post-Graduation and Research (Posgrap), and the Coordination of Research (Copes) awarded a scholarship to this work. The Nova DFL donated the local anesthetics and needles used in the research.
Funding
The work was supported by Coordination of Research (Copes), Department of Dentistry of the Federal University of Sergipe.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Meneses-Santos, D., Amorim, K.S., Dantas, A.C.G.C. et al. Comparison of two vasoconstrictors on glycemic levels in diabetic patients. Clin Oral Invest 24, 4591–4596 (2020). https://doi.org/10.1007/s00784-020-03327-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-020-03327-z